RxDoctor Payments Data

Leonard Merlo, DMD

Oral and Maxillofacial Surgery · Rockville, MDNPI 1346245198

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,163 of the $4,729 with a category attached, or 66.9%. 10 manufacturers reported payments, led by Zimvie Inc. at 49.9% of the total. 2025 is the largest year on record at $1,988, 2.6 times the $757 reported in 2019.

$4,729in general payments, 2019–2025

Across 71 payments — averaging $66.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimvie Inc.$2K
  • Zimmer Biomet$2K
  • ACE Surgical Supply Co., Inc.$84
  • Straumann USA LLC$60
  • Orapharma, A Division Of Bausch Health US, LLC$32
  • Biohorizons Implant Systems Inc.$31
  • plus $67 from 4 others

What the payments were for

  • Travel & lodging$1,54833%
  • Food & beverage$3,16367%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,729 in reported general payments places this provider in the 85th percentile of 173 oral and maxillofacial surgery providers in Maryland.

See all oral and maxillofacial surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$33,798
Medicare patients
90
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin56$237
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$207
Meloxicam19$60

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →